Skip to contentSkip to filters

We use cookies for analytics.

Grant

Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease Registry

Pfizer

Related content

About

German teams can establish or expand a longitudinal registry to study treatment patterns, safety, disease burden and patient outcomes in idiopathic inflammatory myopathies. Proposals should link clinician- and patient-reported data across specialist and routine care.

Topics

Eligibility

Covers: Up to EUR 350,000 over three years. First-year funding is limited to EUR 100,000.

The geographic scope of the call is DE.

cdn.pfizer.compfizer.com

The institution and medically qualified principal investigator must be based in Germany. The principal investigator must be an employee or contractor of the requesting organization.

Source: cdn.pfizer.com